Quarterly report pursuant to Section 13 or 15(d)

License Agreements and Clinical Research Support Agreements (Tables)

v3.8.0.1
License Agreements and Clinical Research Support Agreements (Tables)
 9 Months Ended
Sep. 30, 2017
License Agreement Disclosure [Abstract]  
Research and Development Arrangement, Contract to Perform for Others [Table Text Block]
For the three and nine months ended September 30, 2017 and 2016, the Company recorded the following expense in research and development for licenses acquired:
 
 
 
For the Three Months Ended September 30,
 
 
For the Nine Months Ended September 30,
 
($ in thousands)
 
2017
 
 
2016
 
 
2017
 
 
2016
 
City of Hope
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IL13Ra2
 
$
-
 
 
$
-
 
 
$
250
 
 
$
-
 
IV/ICV
 
 
-
 
 
 
-
 
 
 
125
 
 
 
-
 
PSCA
 
 
-
 
 
 
-
 
 
 
300
 
 
 
-
 
HER2
 
 
-
 
 
 
-
 
 
 
600
 
 
 
-
 
CS-1
 
 
-
 
 
 
-
 
 
 
600
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UCLA
 
 
-
 
 
 
-
 
 
 
200
 
 
 
-
 
Fred Hutch CD20
 
 
300
 
 
 
-
 
 
 
300
 
 
 
-
 
Total
 
$
300
 
 
$
-
 
 
$
2,375
 
 
$
-